MUC16 is highly and stably expressed in the most aggressive and most common subtypes of endometrial cancer Findings support Whitehawk's development of MUC16-directed ADC, HWK-016, currently being ...

Discusses Proposed Acquisitions of Tubulis, Ouro and Arcellx and Strategic Pipeline Expansion April 7, 2026 4:30 PM ...

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will present new research at the American Association for Cancer Research (AACR) Annual Meeting, highlighting ...

Eisai Inc. today announced the presentation of findings from a new survey, which evaluated the experiences and perspectives of 119 U.S.-based patients who have been diagnosed with endometrial cancer ...

AI is making waves in health care and medicine. Does the technology have the potential for breakthroughs in how we tackle ...

OBI Pharma is a clinical-stage global oncology company established in 2002 and headquartered in Taiwan. Together with its subsidiary OBI Pharma USA, Inc., the company is dedicated to developing ...

A new Yale study of roundworms, a species with the unique ability to regenerate, reveals that disruptions in the body's ...

Some researchers hold that evolution hasn’t much altered humans in the past 10,000 years. A new analysis of ancient DNA ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...

This study presents important findings for the understanding of central brain circuits that underlie nociception-induced escape. Using a laser-based nociception assay, chronic neuronal silencing, ...

Hidden within ancient microbial structures, scientists have uncovered a partnership that may mirror one of life’s most ...

Scientists created a definitive E3 ligase atlas, resolving inconsistencies and enabling better disease research and drug ...